跳至主要内容
临床试验/NCT04234373
NCT04234373进行中(未招募)不适用

Understanding Gut-brain Interactions and the Effect of a Low-carb Dietary Intervention in Obese Patients With and Without Glucose Intolerance or Diabetes: a Pilot Trial

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
40
试验地点
1
主要终点
Effect of a low-carb dietary intervention on glycemic control as defined by blood glucose level at 2h after an oral glucose tolerance test.

研究概览

简要总结

Effects of a 6 months low-carb dietary intervention on glycemic control, body composition and gut-brain interaction in obese and lean patients with and without glucose intolerance or diabetes

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Group A: HEALTHY LEAN CONTROLS
  • •Healthy normal weight subjects with a body-mass index of 19.0-24.9kg/m2, HbA1C <5.7% and fasting glucose <5.6 mmol/l
  • •Normal eating habits
  • •Stable body weight for at least three months
  • •Informed Consent as documented by signature
  • •Group B: PRE-DIABETIC or DIABETIC OBESE
  • •Pre-diabetic/Diabetic obese with a HbA1C >5.7% and/or fasting glucose >5.6 mmol/l) and body-mass index > 30kg/m2, otherwise healthy
  • •Normal eating habits
  • •Stable body weight for at least three months
  • •Informed Consent as documented by signature

排除标准

  • •Group A: HEALTHY LEAN CONTROLS
  • •Pre-existing low carb diet (less than 45% of daily energy intake by carbohydrates)
  • •Pre-existing diet (vegetarian, vegan, gluten-free etc.)
  • •Psychiatric illness
  • •Alcohol abuse, (smoking allowed)
  • •Regular intake of medications, (oral contraceptives allowed)
  • •Intake of antibiotics within the last 3 months before inclusion
  • •Regular intake of pro- or prebiotics
  • •Chronic diseases of the gastrointestinal tract, history of gastrointestinal surgery with major changes to the gastrointestinal tract (e.g. bariatric surgery)
  • •Clinically relevant acute or chronic inflammatory disease
  • •Pregnancy
  • •Participation in another study with investigational drug within the 30 days preceding and during the present study.
  • •Group B: PRE-DIABETIC or DIABETIC OBESE
  • •Pre-existing low carb diet (less than 45% of daily energy intake by carbohydrates)
  • •Pre-existing diet (vegetarian, vegan, gluten-free etc.)
  • •Psychiatric illness
  • •Alcohol abuse, (smoking allowed)
  • •Regular intake of medications (except: oral contraceptives, metformin, SGLT-2, statins, and antihypertensive, which are allowed)
  • •Intake of antibiotics within the last 3 months before inclusion
  • •Regular intake of pro- or prebiotics
  • •Chronic diseases of the gastrointestinal tract, history of gastrointestinal surgery with major changes to the gastrointestinal tract (e.g. bariatric surgery)
  • •Clinically relevant acute or chronic inflammatory disease
  • •Pregnancy
  • •Participation in another study with investigational drug within the 30 days preceding and during the present study.

研究组 & 干预措施

Low Carb dietary Intervention

Experimental

干预措施: Low Carb diet (Other)

结局指标

主要结局

Effect of a low-carb dietary intervention on glycemic control as defined by blood glucose level at 2h after an oral glucose tolerance test.

时间窗: Change from baseline to 6 months

次要结局

  • Effect of a low-carb dietary intervention on liver fat fraction as measured with MRI(Change from baseline to 6 months)
  • Effect of a low-carb dietary Intervention on brain network activity as measured with functional MRI(Change from baseline to 6 months)
  • Effect of a low-carb dietary intervention on metabolomics as measured in plasma, urine and stool samples(Change from baseline to 6 months)
  • Effect of a low-carb dietary intervention on body composition as measured with dual-energy x-ray absorptiometry(Change from baseline to 6 months)
  • Effect of a low-carb dietary intervention on gut microbiota composition as measured in stool samples(Change from baseline to 6 months)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验